Röllig Christoph, Nothacker Monika, Wöckel Achim, Weinbrenner Susanne, Wirth Manfred, Kopp Ina, Ollenschläger Günter, Weissbach Lothar
Arztliches Zentrum für Qualität in der Medizin (AZQ), Berlin, Germany.
Onkologie. 2010;33(7):396-400. doi: 10.1159/000315762. Epub 2010 Jun 21.
Evidence-based guidelines are important sources of knowledge in everyday clinical practice. In 2005, the German Society for Urology decided to develop a highquality evidence-based guideline for the early detection, diagnosis and treatment of the different clinical manifestations of prostate cancer. The guideline project started in 2005 and involved 75 experts from 10 different medical societies or medical organizations including a patient organization. The guideline was issued in September 2009 and consists of 8 chapters, 170 recommendations, and 42 statements. Due to the broad spectrum of clinical questions covered by the guideline and the high number of participating organizations and authors, the organizers faced several methodological and organizational challenges. This article describes the methods used in the development of the guideline and highlights critical points and challenges in the development process. Strategies to overcome these problems are suggested which might be beneficial in the development of new evidence-based guidelines in the future.
循证指南是日常临床实践中重要的知识来源。2005年,德国泌尿外科学会决定制定一项关于前列腺癌不同临床表现的早期检测、诊断和治疗的高质量循证指南。该指南项目于2005年启动,有来自10个不同医学协会或医学组织(包括一个患者组织)的75名专家参与。该指南于2009年9月发布,包括8章、170条推荐意见和42条声明。由于该指南涵盖的临床问题范围广泛,参与组织和作者数量众多,组织者面临着一些方法学和组织方面的挑战。本文描述了该指南制定过程中所采用的方法,并突出了制定过程中的关键点和挑战。文中还提出了克服这些问题的策略,这些策略可能对未来制定新的循证指南有益。